Navigation Links
NUVO Surgical Light - Triple Light Head

ProductsNUVO Surgical Light - Triple Light Head
Company NUVO Inc.
Item NUVO Surgical Light - Triple Light Head
Features 
  • On/Off, Pattern Size adjustment and Light Intensity can all be adjusted by the surgeon from within the sterile field.
  • 137,000 Lux (12,700 Footcandles) light intensity from a single 180 Watt bulb.
  • Back-up bulb that illuminates within milliseconds when the primary bulb fails.
  • Spare bulbs are conveniently located in the wall control housing for easy access.
  • Sealed light head combined with ultra cool operation at only 3.71 W/cm2/Fc
  • Color correct light optimized at 4,300°K to ensure accurate patient assessment.
  • Superior shadow control -- the light head will tolerate as much as 70% of the emitted light being blocked before a noticeable change in pattern intensity is witnessed.
  • Drift-free counterbalance arms that are free to rotate continuously at every joint.
Description The Triple Light Head is commonly found in Heart rooms where two light heads are positioned over the chest with the third light head being used to illuminate the leg area when stripping out veins. The triple is also a favorite in trauma rooms should there be a need to work on multiple sites at the same time. With 137,000 Lux output per light head and a healthy 10 inch pattern, this light is equipped to handle the most complex case. Another popular alternative to the triple light is to pair a single light head with a dual light head.
Info NUVO Inc.
Customer Service: (800) 663-1152
Web site: http://www.nuvosurgical.com

Related medicine products :

1. No.12 Surgical Blade
2. No. SM68 Surgical Blade
3. Surgiscribe Surgical Marking Pens
4. Surgical Markers
5. TLS Surgical Markers
6. SQUEEZE-MARK Surgical Markers
7. Ultra MD40 Super Pulse CO2 Surgical Laser
8. Ultra MD 60 Super Pulse CO2 Surgical Laser
9. Ultra MD 80 Super Pulse CO2 Surgical Laser
10. Reliance Mobile Surgical Stretcher
11. Ocular Posner Diagnostic And Surgical Gonioprism
Streck-Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3000. The shelf life is two years from the date of manufacture....
... electrolyte solution manufactured for use as a ... Streck-Diluent III is for use on the ... JT, S-Plus IV, V, VI with three-part ... and 1600. The shelf life is two ...
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Para 12 Plus is a hematology control ... 3500/3700. Assay values are provided for the ... a three-part differential on the CELL-DYN 1600 ... and closed-vial stability is 75 days. Para ...
Medicine Products:
(Date:4/25/2017)... Indianapolis, IN (PRWEB) , ... April 25, 2017 ... ... Washington, D.C., CEOs, CFOs and HR decision-makers are preparing for how his administration ... Life Financial will provide insight into what changes are most likely to make ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in ... to dispensaries and head shops –can’t help but be heartened by the industry’s current ... cannabis odor aptly described as “skunk smell.” At last they can simply, safely ...
(Date:4/25/2017)... ... 25, 2017 , ... There is no better place in South Florida to ... in the May issue of Consumer Reports focused on heart health. , The ... during and after coronary bypass and aortic valve replacement procedures. , Consumer Reports ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: